Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chaojiang Gu

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Biochemistry. Biokhimiia|November 18, 2009
Structure-function analysis of mutant RNA-dependent RNA polymerase complexes with VPgChaojiang Gu, Tao Zeng, Yong Li, et al.
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology|July 24, 2024
[Establishment of a humanized mouse model of HIV-1 infection and quantification of integrated HIV proviral DNA <i>in vivo</i>]Yang Gao, Jiarui Liu, Changjun Wang, et al.
Virus Genes|August 24, 2006
Plus- and minus-stranded foot-and-mouth disease virus RNA quantified simultaneously using a novel real-time RT-PCRChaojiang Gu, Congyi Zheng, Lili Shi, et al.
Virology|June 19, 2026
Generation and evaluation of an EcoHIV mouse model to study HIV-1 integration and expressionWanrong Wei, Ying Zhou, Yan Ma, et al.
Journal of Hematology & Oncology|October 24, 2018
Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and multiple myelomaJinhuan Xu, Qiuxiang Wang, Hao Xu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 13, 2025
Exosomes as nonviral carrier for targeted delivery of CRISPR-Cas12a for therapeutic HIV-1 proviral DNA editingYan Ma, Wanrong Wei, Zihao Yang, et al.
Journal for Immunotherapy of Cancer|August 21, 2025
CD24 recruits tumor-associated neutrophils to promote the progression of hepatocellular carcinomaJun Wang, Hanning Li, Yimeng Liu, et al.
Scientific Reports|June 21, 2022
The third-generation anti-CD30 CAR T-cells specifically homing to the tumor and mediating powerful antitumor activityShangkun Zhang, Chaojiang Gu, Lifang Huang, et al.
Nature Biomedical Engineering|September 11, 2023
Suppression of cytokine release syndrome during CAR-T-cell therapy via a subcutaneously injected interleukin-6-adsorbing hydrogelXianlei Li, Ningqiang Gong, Falin Tian, et al.
Transplantation and Cellular Therapy|August 23, 2021
CD19/CD22 Chimeric Antigen Receptor T Cell Cocktail Therapy following Autologous Transplantation in Patients with Relapsed/Refractory Aggressive B Cell LymphomasYang Cao, Yi Xiao, Na Wang, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Biochemistry. Biokhimiia|November 18, 2009
Structure-function analysis of mutant RNA-dependent RNA polymerase complexes with VPgChaojiang Gu, Tao Zeng, Yong Li, et al.
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology|July 24, 2024
[Establishment of a humanized mouse model of HIV-1 infection and quantification of integrated HIV proviral DNA <i>in vivo</i>]Yang Gao, Jiarui Liu, Changjun Wang, et al.
Virus Genes|August 24, 2006
Plus- and minus-stranded foot-and-mouth disease virus RNA quantified simultaneously using a novel real-time RT-PCRChaojiang Gu, Congyi Zheng, Lili Shi, et al.
Virology|June 19, 2026
Generation and evaluation of an EcoHIV mouse model to study HIV-1 integration and expressionWanrong Wei, Ying Zhou, Yan Ma, et al.
Journal of Hematology & Oncology|October 24, 2018
Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and multiple myelomaJinhuan Xu, Qiuxiang Wang, Hao Xu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 13, 2025
Exosomes as nonviral carrier for targeted delivery of CRISPR-Cas12a for therapeutic HIV-1 proviral DNA editingYan Ma, Wanrong Wei, Zihao Yang, et al.
Journal for Immunotherapy of Cancer|August 21, 2025
CD24 recruits tumor-associated neutrophils to promote the progression of hepatocellular carcinomaJun Wang, Hanning Li, Yimeng Liu, et al.
Scientific Reports|June 21, 2022
The third-generation anti-CD30 CAR T-cells specifically homing to the tumor and mediating powerful antitumor activityShangkun Zhang, Chaojiang Gu, Lifang Huang, et al.
Nature Biomedical Engineering|September 11, 2023
Suppression of cytokine release syndrome during CAR-T-cell therapy via a subcutaneously injected interleukin-6-adsorbing hydrogelXianlei Li, Ningqiang Gong, Falin Tian, et al.
Transplantation and Cellular Therapy|August 23, 2021
CD19/CD22 Chimeric Antigen Receptor T Cell Cocktail Therapy following Autologous Transplantation in Patients with Relapsed/Refractory Aggressive B Cell LymphomasYang Cao, Yi Xiao, Na Wang, et al.
Pageof 2